Cellect Biotechnology Ltd. (APOP)
| Market Cap | 8.84M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -5.65M |
| Shares Out | 3.91M |
| EPS (ttm) | -0.85 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | April 23 |
| Last Price | $2.41 |
| Previous Close | $2.35 |
| Change ($) | 0.06 |
| Change (%) | 2.55% |
| Day's Open | 2.35 |
| Day's Range | 2.35 - 2.50 |
| Day's Volume | 9,046 |
| 52-Week Range | 1.65 - 7.15 |
Cellect Biotechnology Ltd (NASDAQ: APOP) has announced data from the Phase 1/2 study in Israel evaluating ApoGraft technology for Graft versus Host Disease (GvHD), a severe complication of allogeneic he...
TEL AVIV, Israel, March 29, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”), a developer of innovative technology that enables the functional selection of stem cells, today reported...
Cellect Biotechnology Ltd. (NASDAQ: APOP), Immutep Limited (NASDAQ: IMMP), F-star Therapeutics, Inc. (NASDAQ: FSTX), ProQR Therapeutics N.V.
ProQR Therapeutics NV (NASDAQ: PRQR) shares are trading higher by more than 52% after the company reported results Wednesday from its trial of QR-421a in Usher Syndrome, though the stock did not surge i...
APOP stock holders are getting a 1:3 ratio of shares in the tie-up deal. The merger brings together Cellect's stem cell tech with Quoin's rare and orphan diseases focus.
Up to $25 million of funding at $75 million pre-money valuation to be available to the combined company concurrently with the merger
Promising Progress on Clinical D evelopment Progress , Collaboration s and Partnering
Tel Aviv, Israel , Oct. 22, 2020 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), a developer of innovative technology which enables the functional selection of cells facilitating safer ...
Management to Highlight Progress in Bone Marrow Transplant (BMT) and Chimeric Antigen Receptor T Cell (CAR T) Business Collaborations
TEL AVIV, Israel, Aug. 12, 2020 /PRNewswire/ -- Cellect Biotechnology Ltd.
TEL AVIV, Israel, May 21, 2020 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today reported financ...
TEL AVIV, Israel, May 21, 2020 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), a developer of innovative technology which enables the functional selection of stem cells, today reporte...
Cellect Biotechnology Announces Exercise of Warrants for Cash Proceeds of Approximately $1.5 Million
TEL AVIV, Israel, May 12, 2020 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today announced...
Cellect Biotechnology Ltd. (NASDAQ: APOP) shares nearly doubled to start the week after the company announced progress with its bone marrow transplantation process.
Shares of thinly-traded nano-cap biotech Cellect Biotechnology Ltd – ADR (NASDAQ: APOP) are advancing strongly Wednesday.
Cellect Biotechnology (APOP) news for Tuesday includes new patent approvals overseas that have APOP stock soaring higher. The post Cellect Biotechnology News: APOP Stock Rockets 76% on New Patent Approv...
Cellect Biotechnology Ltd – ADR (NASDAQ: APOP) shares are more than doubling following an announcement concerning patents in two regions.
The thinly traded nano-cap penny stock CELLECT BIOTECH/S ADR (NASDAQ: APOP) was soaring Monday.
About APOP
Cellect Biotechnology Ltd., a biotechnology company, engages in developing ApoGraft, a technology platform that functionally selects stem cells to enhance the safety of regenerative medicine and stem cell therapies in Israel. The company develops ApoTainer, a kit for hematopoietic stem cell transplantation procedures. It has collaborations with the denovoMATRIX group of the Technische Universität Dresden to conduct examinations into the tentative synergy between ApoGraft and denovoMAtrix technology for the purpose of evaluating collaborative d... [Read more...]
| Industry Biotechnology | Founded 2011 |
| CEO Shai Yarkoni | Employees 12 |
| Stock Exchange NASDAQ | Ticker Symbol APOP |